Effects of the Type 2 Diabetes-AssociatedPPARGP12A Polymorphism on Progression to Diabetes and Response to Troglitazone-Reference-Cited by-同舟云学术

Effects of the Type 2 Diabetes-AssociatedPPARGP12A Polymorphism on Progression to Diabetes and Response to Troglitazone

Published:2007-04 Issue:4 Volume:92 Page:1502-1509
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Florez Jose C.,Jablonski Kathleen A.,Sun Maria W.,Bayley Nick,Kahn Steven E.,Shamoon Harry,Hamman Richard F.,Knowler William C.,Nathan David M.,Altshuler David

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/92/4/1502/9055463/jcem1502.pdf

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of antidiabetic inhibitors from Allophylus villosus and Mycetia sinensis by targeting α-glucosidase and PPAR-γ: In-vitro, in-vivo, and computational evidence;Saudi Pharmaceutical Journal;2024-01

2. Unveiling clinically significant PPARγ mutations for thiazolidinedione treatment responsiveness through atomistic simulations;International Journal of Biological Macromolecules;2023-12

3. MicroRNAs Associated With Incident Diabetes in the Diabetes Prevention Program;The Journal of Clinical Endocrinology & Metabolism;2022-12-08

4. PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes;Frontiers in Pharmacology;2021-11-23

5. Reclassifying or Declassifying Diabetes? Can Clinical Characteristics Guide Classification and Treatment?;Clinical Dilemmas in Diabetes;2021-11-05